Prescient Therapeutics Limited (PTX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.71 Million | 2.42 Million | 1.88 Million | 1.18 Million | 1.02 Million | 1.64 Million |
| Cost of Revenue | - | 2088.00 | 1403.00 | 474.00 | 904.00 | 1338.00 |
| Gross Profit | 3.71 Million | 2.42 Million | 1.88 Million | 1.18 Million | 1.02 Million | 1.64 Million |
| Operating Expenses | 10.89 Million | 9.88 Million | 7.09 Million | 5.42 Million | 4.49 Million | 5.54 Million |
| Selling, General and Administrative Expenses | 3.92 Million | 3.66 Million | 3.69 Million | 2.93 Million | 1.73 Million | 1.86 Million |
| Research and Development Expenses | 6.97 Million | 6.22 Million | 3.4 Million | 2.49 Million | 2.76 Million | 3.68 Million |
| Other Expenses | - | 2.42 Million | 1.94 Million | 1.22 Million | 1.1 Million | 1.67 Million |
| Cost and Expenses | 10.89 Million | 9.88 Million | 7.09 Million | 5.42 Million | 4.49 Million | 5.54 Million |
| Operating Income | -7.18 Million | -9.88 Million | -7.09 Million | -5.42 Million | -4.49 Million | -5.54 Million |
| Interest Expense | - | - | 6534.00 | 10.61 Thousand | 4190.00 | 3301.00 |
| Income Tax Expense | -3.71 Million | -2.36 Million | -1.75 Million | -1.18 Million | -1.02 Million | -1.63 Million |
| Earnings before Tax | -11.95 Million | -9.37 Million | -6.86 Million | -5.33 Million | -4.35 Million | -5.42 Million |
| Net Income | -8.23 Million | -7 Million | -5.11 Million | -4.14 Million | -3.32 Million | -3.79 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 805.36 Million | 727.52 Million | 647.8 Million | 611.8 Million | 394.26 Million | 244.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 805.31 Million | 727.52 Million | 647.8 Million | 611.8 Million | 394.26 Million | 244.54 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -1.94 | -4.07 | -3.76 | -4.58 | -4.37 | -3.36 |
| Profit Margin | -2.22 | -2.88 | -2.71 | -3.50 | -3.23 | -2.30 |
| EBITDA | -7.18 Million | -7.45 Million | -5.2 Million | -4.24 Million | -3.46 Million | -3.89 Million |
| Earnings Before Tax Margin | -1.94 | -4.07 | -3.76 | -4.58 | -4.37 | -3.37 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.77 Million | 1.93 Million | 1.17 Million | 2.42 Million | 1.25 Million |
| Cost of Revenue | 717.00 | - | - | - | 2088.00 | - |
| Gross Profit | -717.00 | 1.77 Million | 1.93 Million | 1.17 Million | 2.42 Million | 1.25 Million |
| Operating Expenses | 10.89 Million | 4.97 Million | 5.92 Million | 5.61 Million | 9.88 Million | 4.27 Million |
| Selling, General and Administrative Expenses | - | 2.04 Million | 1.87 Million | 1.84 Million | - | 1.82 Million |
| Research and Development Expenses | - | 2.92 Million | 4.04 Million | 3.76 Million | - | 2.45 Million |
| Other Expenses | - | - | - | - | 2.42 Million | - |
| Cost and Expenses | 10.89 Million | 4.97 Million | 5.92 Million | 5.61 Million | 9.88 Million | 4.27 Million |
| Operating Income | -10.89 Million | -3.2 Million | -5.92 Million | -5.61 Million | -9.88 Million | -4.27 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -3.71 Million | -1.77 Million | -1.93 Million | -1.16 Million | -2.36 Million | -1.2 Million |
| Earnings before Tax | -11.95 Million | -4.61 Million | -5.55 Million | -5.28 Million | -9.37 Million | -4.08 Million |
| Net Income | -8.23 Million | -4.61 Million | -3.61 Million | -4.12 Million | -7 Million | -2.87 Million |
| Earnings Per Share Basic | - | -0.01 | -0.00 | -0.01 | - | -0.00 |
| Earnings Per Share Diluted | - | -0.01 | -0.00 | -0.01 | - | -0.00 |
| Weighted Average Shares Outstanding | 805.31 Million | 805.34 Million | 805.3 Million | 762.28 Million | 727.52 Million | 682.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 805.31 Million | 805.31 Million | 805.3 Million | 762.28 Million | 727.52 Million | 682.92 Million |
| Gross Margin | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -1.81 | -2.05 | -3.78 | - | -2.41 |
| Profit Margin | - | -2.61 | -1.87 | -3.51 | -2.88 | -2.30 |
| EBITDA | - | -3.2 Million | -3.98 Million | -4.43 Million | - | -3.01 Million |
| Earnings Before Tax Margin | - | -1.81 | -3.05 | -4.78 | -4.07 | -3.41 |
CENTR
DKSH
5297
SAWAD
WEZ
300515